Question 1

What specific criteria does my child need to meet to qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the CAR-T treatment compare to other options available for my child's condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of CAR-T treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will my child need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

Question 5

What monitoring will be done to ensure my child's safety during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma clinical trial (NCT04204161). Contact the study team or your healthcare provider for specific answers.

What this study is about